Skip to content
Clinical Trials – home

Tapentadol Hydrochloride: A Comprehensive Guide for Patients

1 / 1
trials open to patients / all trials
1+
Countries

In short

This article examines the use of Tapentadol Hydrochloride in clinical trials for managing various types of pain. Tapentadol is a centrally-acting analgesic with a dual mechanism of action, combining mu-opioid receptor agonism and norepinephrine reuptake inhibition. Clinical studies have investigated its effectiveness for conditions like postoperative pain, osteoarthritis, low back pain, and cancer-related pain. The trials assess Tapentadol's efficacy, safety, and tolerability compared to placebo and other pain medications.

At a glance

Drug Name
Tapentadol Hydrochloride
Mechanism of Action
Dual action: mu-opioid receptor agonist and norepinephrine reuptake inhibitor
Formulations Studied
Immediate Release (IR) and Prolonged Release (PR) tablets
Pain Conditions
Postoperative pain, Osteoarthritis, Chronic low back pain, Cancer-related pain
Key Outcome Measures
Pain intensity, Physical function, Quality of life, Global impression of change
Comparators
Placebo, Oxycodone, Paracetamol (Acetaminophen)
Safety Assessments
Adverse events, Tolerability, Laboratory tests, Vital signs
Dosing Strategy
Typically twice daily, with dose adjustments based on efficacy and tolerability
Special Populations
Studies include opioid-naive and opioid-experienced patients
Additional Assessments
Sleep quality, Anxiety and depression scales, Neuropathic pain components

What is Tapentadol Hydrochloride?

Tapentadol hydrochloride is a prescription medication used to treat moderate to severe pain. It is known by the brand names Nucynta and Palexia. Tapentadol is a centrally acting analgesic, which means it works in the brain and spinal cord to reduce pain signals.

What makes tapentadol unique is its dual mechanism of action. It works as both a mu-opioid receptor agonist (similar to traditional opioids) and a norepinephrine reuptake inhibitor. This combination allows it to effectively relieve pain while potentially causing fewer side effects than traditional opioids.

What Conditions Does Tapentadol Treat?

Tapentadol is used to treat various types of moderate to severe pain, including:

  • Chronic pain: Long-lasting pain that persists for months or years
  • Low back pain: Pain in the lower back area, which can be acute or chronic
  • Osteoarthritis pain: Pain caused by wear and tear of joints, particularly in the knee
  • Neuropathic pain: Pain caused by damage or dysfunction of the nervous system
  • Postoperative pain: Pain following surgical procedures, such as bunionectomy (foot surgery)
  • Cancer pain: Pain related to cancer or its treatment

How Does Tapentadol Work?

Tapentadol works in two main ways to relieve pain:

  1. Mu-opioid receptor agonism: It binds to mu-opioid receptors in the brain and spinal cord, which helps to block pain signals.
  2. Norepinephrine reuptake inhibition: It increases the levels of norepinephrine, a neurotransmitter that helps to reduce pain sensations.

This dual action is believed to contribute to tapentadol's effectiveness in treating various types of pain while potentially reducing some of the typical opioid-related side effects.

Tapentadol Formulations

Tapentadol is available in two main formulations:

  1. Immediate Release (IR): This formulation provides quick pain relief and is often used for acute pain or breakthrough pain episodes.
  2. Prolonged Release (PR) or Extended Release (ER): This formulation provides long-lasting pain relief and is typically used for chronic pain conditions. It allows for less frequent dosing, usually twice daily.

Dosing Information

The dosing of tapentadol can vary depending on the specific formulation, the patient's pain intensity, and their previous opioid experience. Here are some general guidelines:

  • For immediate release tapentadol, doses typically range from 50 mg to 100 mg every 4 to 6 hours.
  • For prolonged release tapentadol, starting doses are usually 50 mg twice daily, which can be adjusted upwards as needed.
  • The maximum daily dose of tapentadol (combining both IR and PR formulations) should not exceed 500 mg per day.

It's important to note that dosing should always be determined by a healthcare provider based on individual patient needs and response to the medication.

Effectiveness of Tapentadol

Clinical trials have shown tapentadol to be effective in treating various types of pain:

  • In patients with chronic low back pain or osteoarthritis, tapentadol PR significantly reduced pain intensity compared to baseline.
  • For postoperative pain following bunionectomy, tapentadol IR provided effective pain relief compared to placebo.
  • In cancer pain patients, tapentadol PR was effective in providing sustained pain control.

Many studies also assessed patient-reported outcomes, such as quality of life and overall impression of change, which generally showed improvements with tapentadol treatment.

Potential Side Effects

Like all medications, tapentadol can cause side effects. Common side effects may include:

  • Nausea and vomiting
  • Constipation
  • Dizziness
  • Drowsiness
  • Headache

However, due to its dual mechanism of action, tapentadol may cause fewer opioid-related side effects compared to traditional opioids. It's important to discuss any side effects with your healthcare provider.

Comparisons to Other Pain Medications

Several studies have compared tapentadol to other pain medications:

  • Tapentadol has been compared to oxycodone in various pain conditions, often showing similar efficacy with potentially fewer side effects.
  • In some studies, tapentadol has been compared to morphine, fentanyl, and buprenorphine, with researchers calculating equivalent doses for pain relief.
  • Tapentadol has also been compared to non-opioid pain relievers like paracetamol (acetaminophen) for postoperative pain management.

These comparisons help healthcare providers determine the most appropriate pain management strategy for individual patients.

Questions people often ask

Conditions where Tapentadol Hydrochloride is being studied

Each condition opens its own overview and trial list

Trials with Tapentadol Hydrochloride

Recruiting trials first

See all 1 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.